Progress in Dermatology and Venereology in 2023 as Reflected in the Journal of the European Academy of Dermatology and Venereology

In 2023, the Journal of the European Academy of Dermatology and Venereology highlighted significant advancements in dermatology and venereology. Key studies included a multicentric study on adjuvant melanoma treatment with 1,194 patients showing high recurrence-free survival rates, and a Dutch study on Mohs Micrographic Surgery for basal cell carcinoma in older adults, emphasizing the impact of general morbidity on survival. Other notable research covered the efficacy of a topical mTOR inhibitor for facial angiofibromas, new expert recommendations for vitiligo management, and the development of new treatments for atopic dermatitis and pustular psoriasis. A systematic review on alopecia areata revealed a 75% reduction in quality of life for patients. The journal maintained a high impact factor of 9.2 and introduced three theme issues on melanoma, hair, and vitiligo.